Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 5, 2015, Pages 732-741

  Veeranki, Sudhakar ^a   Winchester, Lee J ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Dystrophin; Epigenetics; Exercise; MicroRNA; MtTFA; NRF 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; DYSTROPHIN; GENOMIC DNA; HOMOCYSTEINE; LACTATE DEHYDROGENASE; MESSENGER RNA; MICRORNA; MICRORNA 31; MICRORNA 494; MICRORNA 499; MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR A; UNCLASSIFIED DRUG; CREATINE KINASE MM; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA BINDING PROTEIN; MIRN494 MICRORNA, MOUSE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NUCLEAR RESPIRATORY FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; EPIGENETICS; EXERCISE; HYPERHOMOCYSTEINEMIA; METABOLIC CAPACITY; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SOLEUS MUSCLE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL LINE; FEMALE; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; IN VITRO STUDY; KNOCKOUT MOUSE; MALE; METABOLISM; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWIMMING;

MUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CREATINE KINASE, MM FORM; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HYPERHOMOCYSTEINEMIA; IN VITRO TECHNIQUES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUSCLE CONTRACTION; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NUCLEAR RESPIRATORY FACTOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWIMMING; TRANSCRIPTION FACTORS;

EID: 84922800794     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.01.008     Document Type: Article

References (53)

1. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care 2010, 33:442-449.
2. Santoro N. Childhood obesity and type 2 diabetes: the frightening epidemic. World J. Pediatr. 2013, 9:101-102.
3. Smyth S., Heron A. Diabetes and obesity: the twin epidemics. Nat. Med. 2006, 12:75-80.
4. Fiuza-Luces C., Garatachea N., Berger N.A., Lucia A. Exercise is the real polypill. Physiology 2013, 28:330-358.
5. Toledo F.G.S., Goodpaster B.H. The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging. Mol. Cell. Endocrinol. 2013, 379:30-34.
6. O'Gorman D.J., Krook A. Exercise and the treatment of diabetes and obesity. Med. Clin. N. Am. 2011, 95:953-969.
7. Mancuso M., Angelini C., Bertini E., Carelli V., Comi G.P., Minetti C., Moggio M., Mongini T., Servidei S., Tonin P., Toscano A., Uziel G., Zeviani M., Siciliano G., Collaborative N.W.I. Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases. Neuromuscul. Disord. 2012, 22:S226-S229.
8. Veeranki S., Tyagi S.C. Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. Int. J. Mol. Sci. 2013, 14:15074-15091.
9. Westerblad H., Place N., Yamada T. Mechanisms of skeletal muscle weakness. Adv. Exp. Med. Biol. 2010, 682:279-296.
10. Blake D.J., Weir A., Newey S.E., Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 2002, 82:291-329.
11. Davies K.E., Nowak K.J. Molecular mechanisms of muscular dystrophies: old and new players. Nat. Rev. Mol. Cell Biol. 2006, 7:762-773.
12. Jahnke V.E., Van Der Meulen J.H., Johnston H.K., Ghimbovschi S., Partridge T., Hoffman E.P., Nagaraju K. Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet. Muscle 2012, 2:16.
13. Landmark-Hoyvik H., Reinertsen K.V., Loge J.H., Kristensen V.N., Dumeaux V., Fossa S.D., Borresen-Dale A.L., Edvardsen H. The genetics and epigenetics of fatigue. PM&R 2010, 2:456-465.
14. Filler K., Lyon D., Bennett J., McCain N., Elswick R., Lukkahatai N., Saligan L.N. Association of mitochondrial dysfunction and fatigue: a review of the literature. BBA Clinical 2014, 1:12-23.
15. Myhill S., Booth N.E., McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2009, 2:1-16.
16. Wredenberg A., Wibom R., Wilhelmsson H., Graff C., Wiener H.H., Burden S.J., Oldfors A., Westerblad H., Larsson N.G. Increased mitochondrial mass in mitochondrial myopathy mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15066-15071.
17. Yamada T., Ivarsson N., Hernandez A., Fahlstrom A., Cheng A.J., Zhang S.J., Bruton J.D., Ulfhake B., Westerblad H. Impaired mitochondrial respiration and decreased fatigue resistance followed by severe muscle weakness in skeletal muscle of mitochondrial DNA mutator mice. J. Physiol. Lond. 2012, 590:6187-6197.
18. Cartoni R., Leger B., Hock M.B., Praz M., Crettenand A., Pich S., Ziltener J.L., Luthi F., Deriaz O., Zorzano A., Gobelet C., Kralli A., Russell A.P. Mitofusins 1/2 and ERR alpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. Lond. 2005, 567:349-358.
19. Weston A.R., Karamizrak O., Smith A., Noakes T.D., Myburgh K.H. African runners exhibit greater fatigue resistance, lower lactate accumulation, and higher oxidative enzyme activity. J. Appl. Physiol. 1999, 86:915-923.
20. Houmard J.A., Weidner M.L., Gavigan K.E., Tyndall G.L., Hickey M.S., Alshami A. Fiber type and citrate synthase activity in the human gastrocnemius and vastus lateralis with aging. J. Appl. Physiol. 1998, 85:1337-1341.
21. Tesch P., Sjodin B., Thorstensson A., Karlsson J. Muscle fatigue and its relation to lactate accumulation and LDH activity in man. Acta Physiol. Scand. 1978, 103:413-420.
22. McArdle A., McArdle F., Jackson M.J., Page S.F., Fahal I., Edwards R.H.T. Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome. Clin. Sci. 1996, 90:295-300.
23. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33:245-254.
24. Mukherji S., Ebert M.S., Zheng G.X.Y., Tsang J.S., Sharp P.A., van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 2011, 43:854-859.
25. Valencia-Sanchez M.A., Liu J.D., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Gene Dev. 2006, 20:515-524.
26. Ntanasis-Stathopoulos J., Tzanninis J.G., Philippou A., Koutsilieris M. Epigenetic regulation on gene expression induced by physical exercise. J. Musculoskel. Neuron 2013, 13:133-146.
27. Kalra B.R., Ghose S., Sood N.N. Homocystinuria with bilateral absolute glaucoma. Indian J. Ophthalmol. 1985, 33:195-197.
28. Watanabe M., Osada J., Aratani Y., Kluckman K., Reddick R., Malinow M.R., Maeda N. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1585-1589.
29. Liu Y., Sugiura Y., Wu F.F., Mi W.T., Taketo M.M., Cannon S., Carroll T., Lin W.C. beta-Catenin stabilization in skeletal muscles, but not in motor neurons, leads to aberrant motor innervation of the muscle during neuromuscular development in mice. Dev. Biol. 2012, 366:255-267.
30. Veeranki S., Givvimani S., Pushpakumar S., Tyagi S.C. Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1alpha and PGC-1alpha levels in muscle fibers during hindlimb ischemia. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H1116-H1127.
31. Senf S.M., Howard T.M., Ahn B., Ferreira L.F., Judge A.R. Loss of the inducible Hsp70 delays the inflammatory response to skeletal muscle injury and severely impairs muscle regeneration. PLoS ONE 2013, 8.
32. Givvimani S., Munjal C., Tyagi N., Sen U., Metreveli N., Tyagi S.C. Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS ONE 2012, 7.
33. Narayanan N., Pushpakumar S.B., Givvimani S., Kundu S., Metreveli N., James D., Bratcher A.P., Tyagi S.C. Epigenetic regulation of aortic remodeling in hyperhomocysteinemia. FASEB J. 2014, 28:3411-3422.
34. Veeranki S., Givvimani S., Pushpakumar S., Tyagi S.C. Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1 alpha and PGC-1 alpha levels in muscle fibers during hindlimb ischemia. Am. J. Physiol. Heart Circ. 2014, 306:H1116-H1127.
35. Watt K.I., Jaspers R.T., Atherton P., Smith K., Rennie M.J., Ratkevicius A., Wackerhage H. Sb431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force. Muscle Nerve 2010, 41:624-629.
36. Russell A.P., Lamon S., Boon H., Wada S., Guller I., Brown E.L., Chibalin A.V., Zierath J.R., Snow R.J., Stepto N., Wadley G.D., Akimoto T. Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J. Physiol. Lond. 2013, 591:4637-4653.
37. Yamamoto H., Morino K., Nishio Y., Ugi S., Yoshizaki T., Kashiwagi A., Maegawa H. MicroRNA-494 regulates mitochondrial biogenesis in skeletal muscle through mitochondrial transcription factor A and Forkhead box j3. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E1419-E1427.
38. Mooren F.C., Viereck J., Kruger K., Thum T. Circulating microRNAs as potential biomarkers of aerobic exercise capacity. Am. J. Physiol. Heart Circ. 2014, 306:H557-H563.
39. Cacchiarelli D., Incitti T., Martone J., Cesana M., Cazzella V., Santini T., Sthandier O., Bozzoni I. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep. 2011, 12:136-141.
40. Wang J.X., Jiao J.Q., Li Q., Long B., Wang K., Liu J.P., Li Y.R., Li P.F. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med. 2011, 17:71-78.
41. Yu L., Yang S.J. Amp-activated protein kinase mediates activity-dependent regulation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha and nuclear respiratory factor 1 expression in rat visual cortical neurons. Neuroscience 2010, 169:23-38.
42. Baar K., Wende A.R., Jones T.E., Marison M., Nolte L.A., Chen M., Kelly D.P., Holloszy J.O. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. Faseb J. 2002, 16:1879-1886.
43. Miller A., Mujumdar V., Shek E., Guillot J., Angelo M., Palmer L., Tyagi S.C. Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessel. 2000, 15:135-143.
44. Goldstein J.A., McNally E.M. Mechanisms of muscle weakness in muscular dystrophy. J. Gen. Physiol. 2010, 136:29-34.
45. Kolling J., Scherer E.B., Siebert C., Marques E.P., Dos Santos T.M., Wyse A.T. Creatine prevents the imbalance of redox homeostasis caused by homocysteine in skeletal muscle of rats. Gene 2014, 545:72-79.
46. Armstrong C.W., McGregor N.R., Butt H.L., Gooley P.R. Metabolism in chronic fatigue syndrome. Adv. Clin. Chem. 2014, 66:121-172.
47. Hammouda O., Chtourou H., Chaouachi A., Chahed H., Ferchichi S., Kallel C., Chamari K., Souissi N. Effect of short-term maximal exercise on biochemical markers of muscle damage, total antioxidant status, and homocysteine levels in football players. Asian J. Sports Med. 2012, 3:239-246.
48. Rouviere C., Corona B.T., Ingalls C.P. Oxidative capacity and fatigability in run-trained malignant hyperthermia-susceptible mice. Muscle Nerve 2012, 45:586-596.
49. Woolstenhulme M.T., Conlee R.K., Drummond M.J., Stites A.W., Parcell A.C. Temporal response of desmin and dystrophin proteins to progressive resistance exercise in human skeletal muscle. J. Appl. Physiol. 2006, 100:1876-1882.
50. Yeung F., Chung E., Guess M.G., Bell M.L., Leinwand L.A. Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res. 2012, 40:7303-7318.
51. Neuman J.C., Albright K.A., Schainske K.L. Exercise prevents hyperhomocysteinemia in a dietary folate-restricted mouse model. Nutr. Res. 2013, 33:487-493.
52. Randeva H.S., Lewandowski K.C., Drzewoski Z., Brooke-Wavell K., O'Callaghan C., Czupryniak L., Hillhouse E.W., Prelevic G.M. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002, 87:4496-4501.
53. Winchester L., Veeranki S., Givvimani S., Tyagi S.C. Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes. Can. J. Physiol. Pharmacol. 2014, 92:575-582.